CytRx Reports Aldoxorubicin

... Read more

CytRx Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin Achieves 191 Target

... Read more

CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in

... Read more

CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue

... Read more

Darnley Bay Enters Into Binding Letter of Intent to Purchase Pine Point

... Read more

New Data Showing Patient Care Individualized by Daxor ’s Precision Blood

... Read more

Dehaier Medical Systems Ltd. Cooperates with China Sciences Group

... Read more

Analysis From Two Institutions Shows Strong Tumor Response, Overall

... Read more

DelMar Pharmaceuticals Receives Institutional Review Board Approval for

... Read more

DelMar Pharmaceuticals Announces Issuance of New Patent on First-in-Class

... Read more